UCSF research scientists and statisticians have developed improved biomarker classifications as part of their research results in the I-SPY 2 trial for high-risk breast cancer patients. The new cancer response subtypes reflect responsiveness to drug treatments and are intended to help clinicians be more precise in how they target therapies.
A new study by researchers at UCSF and Icahn School of Medicine at Mount Sinai shows that hospice patients with dementia are more likely to receive excellent care and have their anxiety and sadness managed than those not on hospice.
The 2022 ALCAL Scoop Scoot is scheduled for Friday, July 15 at 6 p.m. at William Land Park. The family-friendly event raises funds for organizations including the UC Davis Child Life and Creative Arts Therapy Department, which helps bring fund toys, art supplies and more for children in our hospital.
Irvine, Calif. — Researchers at the University of California, Irvine are conducting pioneering research into the concept that unpredictable parental behaviors, together with unpredictable environment, such as lack of routines and frequent disasters, disrupt optimal emotional brain circuit development in children, increasing their vulnerability to mental illness and substance abuse…
The latest advances in cancer care and research will be showcased at the annual American Society of Clinical Oncology (ASCO) Annual Meeting, the world’s largest clinical cancer meeting.
In a new study of Alzheimer’s disease, UCSF reserachers have discovered that a relatively unstudied form of the tau protein associated with neurodegeneration may be a means for better diagnosis and treatment of the disease.
